To submit a help request for a project, click the button below. Before filling out the form, you will be asked to agree to submission terms, then log in with your NIH credentials if you have not done so already. Questions and general inquiries can be emailed to ccbr@mail.nih.gov.
Ask For Help
Upcoming Classes
Recent CCBR Publications
- 12/01/2020 - Genome-wide screens identify lineage- and tumor-specific genes modulating MHC-I- and MHC-II-restricted immunosurveillance of human lymphomas
- 11/09/2020 - Antigenic re-stimulation of virus-specific memory CD8 T Cells requires days of lytic protein accumulation for maximal cytotoxic capacity
- 11/01/2020 - Inhibitory KIR ligands are associated with higher P. falciparum parasite prevalence
- 10/23/2020 - Inborn errors of Type I IFN immunity in patients with life-threatening COVID-19
- 10/22/2020 - Cross-resistance of cisplatin selected cells to anti-microtubule agents: Role of general survival mechanisms
- 10/01/2020 - Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients
- 10/01/2020 - Host gene expression modulated by Zika virus infection of human-293 cells
- 10/01/2020 - A germline 1;3 translocation disrupting the VHL gene: a novel genetic cause for von Hippel-Lindau
- 09/01/2020 - Whole-Exome Profiling of NSCLC Among African Americans
- 09/01/2020 - The genomic landscape of Mongolian hepatocellular carcinoma
- 09/01/2020 - GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3
- 09/01/2020 - The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy
- 08/12/2020 - Glycolytic metabolism of pathogenic T cells enables early detection of GvHD by 13C-MRI
- 08/01/2020 - Protein kinase A inhibitor proteins (PKIs) divert GPCR-Gαs-cAMP signaling toward EPAC and ERK activation and are involved in tumor growth
- 07/28/2020 - Induction of phenotypic changes in HER2-postive breast cancer cells in vivo and in vitro
- 07/01/2020 - Single-cell–derived primary rectal carcinoma cell lines reflect intratumor heterogeneity associated with treatment response